Antisense and RNAi Therapeutics Market Overview:
Antisense and RNAi therapeutics are a class of drugs that target RNA molecules to treat various diseases.
The global Antisense and RNAi Therapeutics market was valued at US$ 1,284.2 million in 2023 and is anticipated to reach US$ 1,881.9 million by 2030, with a CAGR of 5.5% during the forecast period (2024-2030).
Get An Exclusive Sample of The...
